BSE Live
Oct 03, 16:01Prev. Close
1182.45
Open Price
1191.35
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 03, 15:50Prev. Close
1177.30
Open Price
1177.30
Bid Price (Qty.)
1173.10 (1)
Offer Price (Qty.)
0.00 (0)
Profit & Loss account of SMS Lifesciences India (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 344.72 | 332.19 | 353.86 | 384.87 | 286.39 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 32.62 | 41.31 | 37.57 | 28.94 | |
Revenue From Operations [Net] | 344.72 | 299.56 | 312.55 | 347.30 | 257.46 | |
Total Operating Revenues | 344.72 | 305.96 | 315.56 | 349.74 | 265.59 | |
Other Income | 4.86 | 3.83 | 3.07 | 2.07 | 1.78 | |
Total Revenue | 349.58 | 309.79 | 318.63 | 351.81 | 267.37 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 149.91 | 150.19 | 171.33 | 204.47 | 135.17 | |
Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Operating And Direct Expenses | 0.00 | 57.63 | 56.60 | 65.07 | 50.21 | |
Changes In Inventories Of FGWIP And Stock In Trade | 4.15 | 0.97 | 0.08 | -9.79 | 1.87 | |
Employee Benefit Expenses | 59.54 | 49.27 | 43.43 | 39.90 | 30.66 | |
Finance Costs | 8.71 | 10.16 | 6.79 | 6.17 | 4.53 | |
Depreciation And Amortisation Expenses | 15.00 | 14.94 | 10.79 | 10.01 | 7.86 | |
Other Expenses | 86.09 | 16.78 | 15.38 | 15.93 | 17.51 | |
Total Expenses | 323.39 | 299.94 | 304.39 | 331.77 | 247.81 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 26.19 | 9.85 | 14.24 | 20.04 | 19.57 | |
Exceptional Items | 0.00 | 0.00 | 2.35 | 12.69 | 0.00 | |
Profit/Loss Before Tax | 26.19 | 9.85 | 16.59 | 32.73 | 19.57 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 7.46 | 4.25 | 3.50 | 8.50 | 5.27 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 0.00 | -0.53 | 2.07 | -0.13 | 1.14 | |
Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 7.46 | 3.52 | 5.22 | 7.43 | 6.01 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 18.73 | 6.33 | 11.38 | 25.30 | 13.56 | |
Profit/Loss From Continuing Operations | 18.73 | 6.33 | 11.38 | 25.30 | 13.56 | |
Profit/Loss For The Period | 18.73 | 6.33 | 11.38 | 25.30 | 13.56 | |
Minority Interest | 1.38 | 2.77 | 0.09 | 0.02 | 0.00 | |
Consolidated Profit/Loss After MI And Associates | 20.11 | 9.09 | 11.46 | 25.32 | 13.56 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 67.00 | 30.00 | 38.00 | 84.00 | 45.00 | |
Diluted EPS (Rs.) | 67.00 | 30.00 | 38.00 | 84.00 | 45.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 0.45 | 0.45 | 0.45 | 0.00 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
08.09.2025
SMS Lifescience Standalone June 2025 Net Sales at Rs 79.04 crore, down 8.7% Y-o-Y
12.06.2025
SMS Lifescience Standalone March 2025 Net Sales at Rs 85.43 crore, down 1.1% Y-o-Y
04.06.2025
SMS Lifescience Consolidated March 2025 Net Sales at Rs 89.11 crore, down 0.98% Y-o-Y
04.03.2025
SMS Lifescience Consolidated December 2024 Net Sales at Rs 84.60 crore, up 17.41% Y-o-Y
08.09.2025
SMS Lifescience Standalone June 2025 Net Sales at Rs 79.04 crore, down 8.7% Y-o-Y
12.06.2025
SMS Lifescience Standalone March 2025 Net Sales at Rs 85.43 crore, down 1.1% Y-o-Y
04.06.2025
SMS Lifescience Consolidated March 2025 Net Sales at Rs 89.11 crore, down 0.98% Y-o-Y
04.03.2025
SMS Lifescience Consolidated December 2024 Net Sales at Rs 84.60 crore, up 17.41% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017